You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 9,593,098


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,593,098 protect, and when does it expire?

Patent 9,593,098 protects LAZCLUZE and is included in one NDA.

This patent has fifty-seven patent family members in twenty-four countries.


Drugs Protected by US Patent 9,593,098

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Janssen Biotech LAZCLUZE lazertinib mesylate TABLET;ORAL 219008-001 Aug 19, 2024 RX Yes No ⤷  Subscribe ⤷  Subscribe Y Y FIRST-LINE TREATMENT OF ADULTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) WITH EGFR EXON 19 DELETIONS OR EXON 21 L858R SUBSTITUTION MUTATIONS, IN COMBINATION WITH AMIVANTAMAB ⤷  Subscribe
Janssen Biotech LAZCLUZE lazertinib mesylate TABLET;ORAL 219008-002 Aug 19, 2024 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y FIRST-LINE TREATMENT OF ADULTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) WITH EGFR EXON 19 DELETIONS OR EXON 21 L858R SUBSTITUTION MUTATIONS, IN COMBINATION WITH AMIVANTAMAB ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,593,098

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015331166 ⤷  Subscribe
Brazil 112017007769 ⤷  Subscribe
Canada 2962914 ⤷  Subscribe
China 106795144 ⤷  Subscribe
China 111686110 ⤷  Subscribe
Cyprus 1122737 ⤷  Subscribe
Cyprus 1124359 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.